Antibody recognizing arbitrarily designed epitope of three or more amino acid residues in a peptide and method of generating thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 26, 2020
Grant Date -
Mar 20, 2014
app pub date -
Sep 17, 2012
filing date -
Sep 17, 2012
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Peptide vaccine that is a mixture of different peptide species, where each species has a number of fixed amino acid residues and a number of randomized residues. The fixed resides are the same amino acid residues at the corresponding positions in each species of the mixture while the randomized residues are randomly any available candidate amino acids chosen by design. The degree of randomization may be also been chosen according to the design under a particular situation. This type of peptide vaccines have shown to be able to induce highly specific antibodies against epitopes that are otherwise difficult to induce antibodies in vitro, for example the GPG triplet in the V3 of HIV-1 gp120.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully